-
The ECG shown was obtained as part of a routine "pre-op evaluation" for a markedly overweight young adult scheduled for bariatric surgery
-
THE FDA HAS APPROVED THE FIRST NEW WEIGHT LOSS DRUG in more than a decade.
-
Clinical Briefs: Another Look at Bleeding Risk from Aspirin; Can Aspirin Prevent Recurrence of Thromboembolism?; A New Approach to Tinnitus
-
While regular exercise is beneficial to overall health, repeated long-term endurance exercise — such as marathons, ultramarathons, ironman triathlons, and long-distance bicycle racing — may cause myocardial scarring and increase the risk of serious arrythmias, coronary artery calcification, diastolic dysfunction, and large-artery wall stiffening.
-
People using oral bisphosphonates for the first time may be at a higher risk of developing ocular inflammatory adverse events such as scleritis and uveitis.
-
-
"By the time we learned this was a problem around the country, the information from Tennessee had already narrowed it down to what the problem was. [It was] a textbook case of how to do it right." Paul Jarris, MD, executive director of the Association of State and Territorial Health Officials.
-
A compounding-pharmacy assessment tool developed by the American Society of Health-System Pharmacists (ASHP) can provide critical guidance for hospitals in the wake of the national meningitis outbreak.
-
The Centers for Disease Control and Prevention's rapidly expanding National Healthcare Safety Network (NHSN) has long been the gold standard surveillance system for health care associated infections (HAIs).
-